Related Experiment Video
Updated: Jun 29, 2026

Automated Midline Shift and Intracranial Pressure Estimation based on Brain CT Images
Published on: April 13, 2013
Quantitative Perihematomal Imaging Analysis for the Prediction of Intracerebral Hematoma Expansion
Yuval Wiesel1, Michael Findler1, Jonathan Naftali1
1From the Department of Neurology (Y.W., M.F., J.N., R.B., E.A.), Rabin Medical Center, Petah Tikva, Israel and Department of Neurology (A.H.), Soroka Medical Center, Be'er Sheva, Israel.
Background And Purpose:
Hematoma expansion (HE) is a major cause of early neurological deterioration and poor outcome in spontaneous intracerebral hemorrhage (ICH). The perihematomal region (PHR), a potential site of secondary vascular injury, remains poorly characterized. We evaluated whether quantitative PHR features provide predictive information for HE beyond hematoma features and insight into HE dynamics.
Materials And Methods:
In this retrospective two-center study, 149 patients with acute ICH underwent baseline CT within 24 hours of symptom onset and follow-up CT within 72 hours. HE was defined as >6 mL or >33% hematoma growth on follow-up CT. Hematoma and perihematomal regions were segmented using relative (half- and full-radius) and absolute (2, 5, and 10 mm) definitions. Radiomic features were extracted and modeled using multivariable logistic regression. Clinical predictors were added to create combined clinical-radiomic models, and performance was evaluated on an independent test set.
Results:
HE occurred in 29% (44/149) of patients. The hematoma-only radiomic model showed modest discrimination (AUC=0.71, 95% CI 0.62-0.80). Incorporating PHR features improved performance, with the absolute 5-mm PHR model achieving the highest discrimination (AUC=0.91, 95% CI 0.86-0.95). Adding clinical predictors further enhanced performance (AUC=0.94, 95% CI 0.90-0.97). Key PHR features associated with HE included reduced sphericity, increased texture coarseness, and clustered heterogeneity.
Conclusions:
Quantitative PHR characterization was strongly associated with HE and provided incremental value beyond hematoma-derived radiomics, with further improvement when combined with clinical predictors. This contrast-free approach may support objective risk stratification, guide targeted interventions and reduce expansion related morbidity.

